Lexent Bio Revenue, Growth & Competitor Profile

DBA Impact Genomics, Inc.

Company Profile & Annual Report for Lexent Bio

Access the complete profile.

Lexent Bio Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	1000 Brannan St Suite 402 San Francisco, CA 94103

Note: Revenues for privately held companies are statistical evaluations.


Lexent Bio's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lexent Bio's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Lexent Bio is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Lexent Bio Annual Revenue and Growth Rate

Lexent Bio	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lexent Bio's revenues are gauged from an analysis of company filings.

Lexent Bio's Income Statement (based on Industry Averages)

Lexent Bio P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Lexent Bio is developing and marketing. Lexent Bio doesn't have any recent trademark applications, indicating Lexent Bio is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LEXENT BIO Genomic and molecular medical testing for diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing, monitoring and reporting services for cancer and other diseases and disorders; providing medical data and information to healthcare professionals	12/08/2016

See all trademarks and details in the Full Report.

Market Share of Lexent Bio's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lexent Bio, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Lexent Bio. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
OPENAI	San Francisco, CA	100
J.DAVID GLADSTONE INSTITUTES	San Francisco, CA	73
FIRSTLAYERAI	San Francisco, CA	67
EMBARK TRUCKS	San Francisco, CA	65
IDEO	San Francisco, CA	60
NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH & EDUCATION	San Francisco, CA	37

Other Companies at 1000 Brannan St, San Francisco CA

Company	Headquarters	Revenue ($ MM)
NIBBI BROS. ASSOCIATES	San Francisco, CA	100
RINSE	San Francisco, CA	14
BILL MCKENNA & ASSOCIATES	San Francisco, CA	8
HEALTH LINK	San Francisco, CA	4
NICHE INTERIORS	San Francisco, CA	0

Future Competition: Lexent Bio's Fastest Growing Competitors

These companies are in the same general field as Lexent Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)